FT : Trading giant Jane Street seeks to double London office footprint

Trading giant Jane Street seeks to double London office footprint
New York-based group in talks for up to 500,000 sq ft of City space

Jane Street is seeking to double its London office space, as the trading firm rides a period of explosive growth that has established it as a challenger to the world’s biggest banks.

The firm has been in talks with landlords about increasing its City of London office space to 400,000-500,000 square feet in the next few years, according to people familiar with the matter.

The New York-based group currently occupies about 235,000 sq ft at 2½ Devonshire Square near Liverpool Street. It has already increased its space there once since moving in five years ago, upsizing from 70 per cent occupancy to take the whole building in 2022.

Earlier this year Jane Street agreed to expand its New York office to roughly 1mn sq ft.

A 500,000 sq ft London office would be close to the size of HSBC’s new global headquarters at St Paul’s — which is around 550,000 sq ft — although that is now thought to be too small for the bank.

Jane Street is one of the world’s best known trading firms, along with other industry giants such as Ken Griffin’s Citadel Securities and Jeff Yass’s Susquehanna. The firm makes markets in assets including exchange traded funds, equities and bonds; buying and selling securities at high speeds for often small profits in each trade.

The firm was relatively unknown for much of the 2010s, but its revenues and profits exploded during the Covid-19 pandemic as market volatility jumped and demand for its trading services surged.

It made net trading revenues of $8.4bn in the first half of last year, on a par with the biggest Wall Street banks, and has expanded to more than 2,600 employees across offices including London, New York, Hong Kong and Singapore.

Rival hedge fund Citadel and its sister firm, market maker and direct competitor Citadel Securities, have agreed to lease at least 250,000 sq ft at British Land’s 2 Finsbury Avenue skyscraper nearby at Broadgate when it completes in 2027 — a two-thirds expansion of Citadel’s London presence.

Citadel has options to expand its office by up to 130,000 sq ft, which agents expect they are likely to exercise.

Jane Street has considered a move to the Dovetail Building, a new 23-storey tower with roughly 465,000 sq ft of office space, which is being developed for completion in 2029.

The trading firm is also potentially looking at the former Deutsche Bank headquarters on London Wall and other options in the City, one of the people said, adding that no decision had been made.

Relatively few large buildings suitable for big financial businesses are set to be delivered in the City over the coming years, because of a pause on new developments getting started during Covid-19 and the recent period of high interest rates and construction costs.

Jane Street did not respond to a request for comment.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • XPOF -29.5% (also restates 2023 financials), AIRS -15%, LI -6.4%, AVD -3.2% (files to delay its 10-K; also discloses preliminary results for fourth quarter) EVCM -3.1%, ZUMZ -3% (also authorizes new $25 mln share repurchase program), MRC -2.3%, ATYR -2%, OI -1.5%, DOYU -1.1%
Other news:
  • STRO -13.6% (CEO to step down, provides portfolio review update, will reduce headcount by nearly 50%, also reports earnings)
  • IVT -3.7% (increases dividend)
  • NRIX -2.9% (treatment of Waldenstrom macroglobulinemia gets orphan status)
  • CPA -2.5% (February traffic)
  • BYRN -1.2% (begins ammo production at Indiana facility)
  • SSP -1.1% (signs deal with Las Vegas Aces)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • RBRK +18.2%, CLLS +16.3%, GOGO +13.1%, SMTC +11%, DOCU +10.1%, WOW +9.4%, TTAN +7.5%, CCI +7.4% (also to sell its Fiber segment for $8.5 bln; announces $3 bln repurchase plan, to cut dividend), AFYA +7%, ULTA +5.9%, BKE +5.3%, RLX +5.1%, PD +4.2% (also authorizes new $150 mln share repurchase program), WPM +2.4% (also increases dividend), WRD +1.2%
Other news:
  • RDUS +109.6% (to be acquired by Toyota Tsusho America)
  • AAOI +53% (issues warrant to AMZN to purchase shares)
  • ETON +13.1% (positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of desmopressin under development for the treatment of central diabetes insipidus)
  • PPC +5.4% (approves special dividend of $6.30 per share)
  • VTLE +4.6% (files mixed shelf securities offering)
  • IPG +3.4% (IPG and OMC receive second request from FTC relating to proposed acquisition)
  • ALCO +3.4% (files development application for first of two villages)
  • ALAB +2.9% (expands its Cloud-Scale Interop Lab)
  • PLTR +2.6% (Warp Speed announces 6 new customers)
  • BV +2.4% (authorizes new $100 mln share repurchase program)
  • CNL +2.4% (Collective Mining: Agnico Eagle (AEM) agreed to subscribe for 4,741,984 common shares in the capital of the Company at a price of C$11.00 per Share)
  • XYZ +2.1% (Square Financial receives FDIC approval to offer Cash App Borrow)
  • TEL +1.7% (increases dividend)
  • AEM +1.3% (Collective Mining: Agnico Eagle (AEM) agreed to subscribe for 4,741,984 common shares in the capital of the Company at a price of C$11.00 per Share)
  • FAST +1.2% (releases Investor Day presentation yesterday)
  • WPC +1.1% (increases dividend)
  • DBRG +1.1% (Zayo unit to acquire CCI's Fiber Solutions business)
  • FF +1.1% (to delay release of FY24 results)
  • ITGR +1.1% (prices offering of $875.0 mln of 1.875% convertible senior notes due 2030)
  • ANIP +1.1% (FDA approval for expansion of ILUVIEN label)
  • ORLY +1% (approves 15-for-1 stock split)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • RDUS +109.4%, AAOI +55.1%, CLLS +22.5%, RBRK +20.7%, SMTC +12.3%, DOCU +9.4%, CCI +8%, ULTA +7.2%, AFYA +7%, NRIX +6.1%, TTAN +5.9%, BLNK +5.5%, VTLE +4.6%, PD +4.5%, PPC +4.3%, RLX +4.3%, IPG +3.4%, ALCO +3.4%, ALAB +2.6%, WRD +2.5%, EGY +2.4%, PLTR +2.3%, BV +2%, XYZ +1.8%, WPM +1.8%, TEL +1.7%, CNL +1.2%, WPC +1%, AEM +1%
  • Gapping down:
    • XPOF -33.3%, STRO -14.4%, LI -5.1%, IVT -3.7%, AVD -3.2%, ZUMZ -3%, EVCM -2.6%, CPA -2.5%, WMB -2.1%, OI -1.5%, AIRS -1.4%, BYRN -1.2%, DOYU -1.1%, EQT -1%

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Allogene (ALLO) upgraded to Mkt Outperform from Mkt Perform at Citizens JMP; tgt $5
    • American Express (AXP) upgraded to Neutral from Underperform at Robert W. Baird; tgt $265
    • Check Point Software (CHKP) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $280
    • Chipotle Mexican Grill (CMG) upgraded to Buy from Hold at Loop Capital; tgt raised to $65
    • Crown Castle (CCI) upgraded to Strong Buy from Outperform at Raymond James; tgt lowered to $122
    • Crown Castle (CCI) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $120
    • Danaher (DHR) upgraded to Buy from Hold at Stifel; tgt $260
    • Green Dot (GDOT) upgraded to Buy from Hold at Craig Hallum; tgt $14
    • MYR Group (MYRG) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $136
    • National Cinemedia (NCMI) upgraded to Outperform from Neutral at Wedbush; tgt $7.50
    • Nektar Therapeutics (NKTR) upgraded to Outperform from Perform at Oppenheimer; tgt $6
    • Nuvalent (NUVL) upgraded to Buy from Neutral at UBS; tgt $100
    • Peloton (PTON) upgraded to Buy from Hold at Canaccord Genuity; tgt $10
    • Philip Morris International (PM) upgraded to Buy from Hold at Argus
    • RELX (RELX) upgraded to Overweight from Equal Weight at Barclays
    • Revolve Group (RVLV) upgraded to Buy from Hold at Jefferies; tgt $30
    • Skyward Specialty Insurance Group (SKWD) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $63
  • Downgrades:
    • Advanced Flower Capital (AFCG) downgraded to Hold from Buy at Jefferies; tgt lowered to $7
    • Copart (CPRT) downgraded to Hold from Buy at Argus
    • Equifax (EFX) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $265
    • Sutro Biopharma (STRO) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $1
    • Sutro Biopharma (STRO) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $2
    • Sutro Biopharma (STRO) downgraded to Mkt Perform from Mkt Outperform at Citizens JMP
    • T-Mobile US (TMUS) downgraded to Neutral from Buy at Citigroup; tgt $268
    • Xponential Fitness (XPOF) downgraded to Hold from Buy at Stifel; tgt lowered to $12
  • Others:
    • 89bio (ETNB) initiated with a Neutral at Goldman; tgt $11
    • ANI Pharma (ANIP) initiated with a Buy at Jefferies; tgt $80
    • Astera Labs (ALAB) initiated with an Outperform at Raymond James; tgt $82
    • Avient (AVNT) initiated with a Neutral at Robert W. Baird; tgt $43
    • Charter Comm (CHTR) resumed with a Buy at Citigroup; tgt $425
    • Corporación América Airports (CAAP) initiated with an Overweight at JP Morgan; tgt $22.50
    • Penumbra (PEN) initiated with a Buy at BofA Securities; tgt $320
    • Protara Therapeutics (TARA) initiated with an Overweight at Cantor Fitzgerald
    • Sana Biotechnology (SANA) initiated with a Buy at Jefferies; tgt $7
    • Six Flags Entertainment (FUN) initiated with an Overweight at Barclays; tgt $41
    • United Parks & Resorts Inc. (PRKS) initiated with an Equal Weight at Barclays; tgt $50
    • Viper Energy Partners (VNOM) initiated with an Overweight at Wells Fargo; tgt $51
    • Waystar Holding Corp. (WAY) initiated with a Buy at Truist; tgt $45

>>> Europe : Brokers Upgrades & Downgrades - 14th of March 2025 V2(+)

>>> Up
* Adecco Raised to Outperform at BNPP Exane (+)
* Ahold Raised to Buy at Goldman Amid ‘Solid’ Retail Sales Outlook
* Atlantic Sapphire ASA Raised to Neutral at SpareBank
* AUTO1 Raised to Outperform at BNPP Exane (+)
* Carel Raised to Hold at Kepler Cheuvreux
* Carlsberg Raised to Outperform at RBC; PT 1,020 kroner
* Erste Raised to Outperform at KBW; PT 80 euros
* Hays Raised to Outperform at BNPP Exane (+)
* Heineken Raised to Outperform at RBC; PT 92 euros
* Kuehne + Nagel Raised to Buy at Kepler Cheuvreux
* Micron Raised to Buy at Aletheia Capital; PT $145
* Novo Raised to Outperform at Oddo BHF; PT 720 kroner
* Redcare Pharmacy NV Raised to Buy at Kepler Cheuvreux
* RELX Raised to Overweight at Barclays; PT 4,275 pence
* Rightmove PT Raised to 840 pence from 700 pence at Peel Hunt
* Schneider Electric Raised to Buy at DZ Bank; PT 270 euros
* Siemens Healthineers Raised to Outperform at Oddo BHF (+)
* SUSS MicroTec Raised to Buy at DZ Bank; PT 52 euros

>>> Down
* AIB Group Cut to Neutral at JPMorgan; PT 7.30 euros
* Biovica International Cut to Hold at Pareto Securities
* Forbo Cut to Reduce at Baader Helvea; PT 881 Swiss francs
* Generali Cut to Sell at DZ Bank; PT 29 euros
* Hugo Boss Cut to Hold at Deutsche Bank; PT 45 euros
* Hugo Boss Cut to Neutral at UBS (+)
* Novartis Cut to Neutral at Oddo BHF; PT 110 Swiss francs
* Prosus Cut to Neutral at Prescient Securities; PT 49 euros
* Puma Cut to Sell at UBS (+)
* RS Group Cut to Neutral at BNPP Exane (+)
* T-Mobile Cut to Neutral at Citi; PT $268
* Tecan PT Cut to 205 Swiss francs at Bank Vontobel
* Thyssenkrupp Cut to Underweight at Morgan Stanley; PT 6.60 euros
* Vienna Insurance Cut to Neutral at Oddo BHF; PT 38 euros

>>> Initiation
* Alcon AG Re-Initiated Outperform at Bernstein (+)
* Amplifon Re-Initiated Market Perform at Bernstein (+)
* Autostore Rated New Buy at Deutsche Bank; PT 14.10 kroner (+)
* Canal+ SA Rated New Buy at Deutsche Bank; PT 240 pence
* Carl Zeiss Meditec Re-Initiated Outperform at Bernstein (+)
* Demant Re-Initiated Market Perform at Bernstein; PT 271 kroner (+)
* GN Store Nord Re-Initiated Underperform at Bernstein (+)
* Halcor Rated New Buy at Kepler Cheuvreux; PT 2.60 euros
* Sonova Re-Initiated Market Perform at Bernstein (+)
* Straumann Re-Initiated Outperform at Bernstein (+)
* Wise Rated New Sell at Investec; PT 800 pence (+)

>>> Call
* AIB Downgraded to Neutral at JPMorgan on Tariff and Tax Risks (+)
* Barclays Strategists Favor European Value Stocks and Small Caps (+)
* Burberry, Kering Placed on Negative Catalyst Watch at JPMorgan
* Carlsberg, Heineken Upgraded at RBC on ‘Prudent’ Expectations
* Puma Cut to Sell at UBS as Further Underperformance Expected (+)